Abstract
Purpose: To investigate the influence of the combined use of platelet-rich fibrin (PRF) and narrow-band UV B (NB-UVB) treatment on small-area deep burn wounds. Methods: 86 patients with small area deep burn wounds were assigned to control (routine drugs + NB-UVB) and study groups (PRF + NB-UVB). Results: The study group showed significantly lower serum levels of TNF-α and IL-8 post-treatment compared to the control group (p < 0.001). Wound healing time (20.6 vs 40.3 days) and dressing change frequency (7.1 vs 20.5 times) were also significantly reduced in the study group (p < 0.001). Conclusion: Combined PRF and NB-UVB therapy effectively lowers inflammatory factors and accelerates healing in small area deep burns.
Introduction
Deep burn wounds, specifically deep second-degree and third-degree burns, present significant clinical challenges. Damage extending into the dermis necessitates prolonged recovery, frequent and often painful dressing changes, and carries a high risk of hypertrophic scarring. While standard pharmacological and surgical interventions are available, there is a critical need for therapies that can simultaneously accelerate tissue regeneration and modulate the inflammatory environment. This study evaluates the efficacy of combining autologous platelet-rich fibrin (PRF) with narrow-band ultraviolet B (NB-UVB) phototherapy.
Methods
The study involved 86 patients with small-area deep burn wounds (3–30 cm²) treated at Shandong Provincial Third Hospital. Participants were randomized into two equal groups (n=43). Baseline characteristics, including age, gender, and burn surface area, were statistically comparable between groups, ensuring a balanced starting point for the intervention.
- Control Group: Received routine drug therapy combined with NB-UVB phototherapy.
- Study Group: Received autologous PRF application combined with NB-UVB phototherapy.
Platelet-Rich Fibrin (PRF) was prepared from the patient's own venous blood via centrifugation to isolate a fibrin matrix rich in platelets, leukocytes, and cytokines. This matrix serves as a bioactive scaffold for tissue repair. NB-UVB phototherapy utilized radiation at 311–312 nm, known for its ability to suppress local and systemic inflammatory responses.
Results
The integration of PRF and NB-UVB yielded superior clinical outcomes across all measured indices.
Clinical Healing Indices
The study group demonstrated a dramatic reduction in recovery time. Healing was achieved in approximately half the time required for the control group. Furthermore, the frequency of dressing changes—a major source of patient discomfort and healthcare cost—was significantly lower in the PRF-treated group.
Inflammatory Response
Serum levels of pro-inflammatory cytokines TNF-α and IL-8 were measured to assess the systemic inflammatory state. While both groups showed a reduction in these markers post-treatment, the decline was significantly more pronounced in the study group. For instance, post-treatment TNF-α levels in the study group were 65.42 ± 5.33 ng/L compared to 114.68 ± 2.53 ng/L in the control group.
Scarring and Complications
The incidence of scar hyperplasia was notably lower in the study group (11.6%) compared to the control group (86.0%), suggesting that the combined therapy not only speeds up healing but also improves the quality of the regenerated tissue.
Discussion
The efficacy of this combined approach likely stems from a synergistic mechanism. PRF provides a trimolecular stereo-reticular biological scaffold that mimics natural tissue, facilitating the slow release of growth factors and supporting nutrient transport. Simultaneously, NB-UVB phototherapy modulates the inflammatory milieu, preventing the excessive cytokine production that often leads to delayed healing and scarring.
Conclusion
The combined use of PRF and NB-UVB phototherapy represents a promising advancement in the management of small-area deep burn wounds, offering faster healing, reduced pain through fewer dressing changes, and superior aesthetic outcomes. However, larger multi-center trials and longer follow-up periods are necessary to confirm these findings and establish standardized clinical protocols.
Summary updated